Autonomix Medical (NASDAQ:AMIX) Stock Price Up 18.6% – Time to Buy?

Shares of Autonomix Medical, Inc. (NASDAQ:AMIX) rose 18.6% during mid-day trading on Thursday . The company traded as high as $0.41 and last traded at $0.3990. Approximately 1,063,574 shares changed hands during trading, a decline of 42% from the average daily volume of 1,847,096 shares. The stock had previously closed at $0.3365.

Analyst Upgrades and Downgrades

AMIX has been the subject of a number of analyst reports. Weiss Ratings upgraded Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Monday. Maxim Group cut their price target on Autonomix Medical from $5.00 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, February 17th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Autonomix Medical has an average rating of “Hold” and a consensus price target of $2.00.

Autonomix Medical Stock Performance

The business has a 50 day moving average price of $0.39 and a two-hundred day moving average price of $0.53. The stock has a market cap of $2.76 million, a PE ratio of -0.11 and a beta of -1.82.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.